To investigate a potential role for stromelysin-1 (MMP-3) in the development and progression of atherosclerotic lesions and aneurysm formation, mice with a deficiency of apolipoprotein E (ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ) ) or with a combined deficiency of apoE and MMP-3 (ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ ) were kept on a cholesterol-rich diet for 30 weeks. Atherosclerotic lesions throughout the thoracic aorta were significantly larger in ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ than in ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice (PϽ0.05) and contained more fibrillar collagen (PϽ0.01). Aneurysms in the thoracic and abdominal aortas were less frequent in ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ than in ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice (8.5Ϯ1.7% vs 14Ϯ2.1% of sections, meanϮSD, PϽ0.01). Immunocytochemistry revealed enhanced accumulation of macrophages in atherosclerotic lesions of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice (PϽ0.01) and expression of urokinase-type plasminogen activator (u-PA) and MMP-3 colocalizing with macrophages. Zymography confirmed the presence of u-PA and MMP-3 activity in extracts of atherosclerotic aortas. These data suggest that plasmin, generated by macrophage-secreted u-PA, activates pro-MMP-3 produced by accumulated macrophages. MMP-3 activity may then contribute to a reduction of plaque size, possibly by degradation of matrix components, and promote aneurysm formation by degradation of the elastica lamina.
A therosclerotic lesions initially consist of fatty streaks that develop into fibroproliferative lesions. 1, 2 A mature lesion consists mainly of foam cells, smooth muscle cells (SMCs), a necrotic core, and a fibrous cap containing extracellular matrix components. Clinical complications of atherosclerosis are often triggered by rupture of unstable plaques, whereas thinning of the atherosclerotic vessel wall due to elastin and collagen degradation and media necrosis may result in aneurysm formation and bleeding. Proteolysis may contribute to neovascularization and rupture of plaques or to ulceration and rupture of aneurysms. A potential role for increased proteolysis by plasmin or matrix metalloproteinases (MMPs) is suggested by the enhanced expression of tissuetype plasminogen activator, urokinase-type plasminogen activator (u-PA), and several MMPs in atherosclerotic plaques. [3] [4] [5] [6] MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, and membrane type (MT)1-MMP, as well as their tissue inhibitors (TIMP-1, TIMP-2, and TIMP-3), are expressed in atherosclerotic tissue. [7] [8] [9] [10] [11] [12] Analysis of atherosclerotic aortas in mice with a combined deficiency of apoE and u-PA revealed that u-PA deficiency protected against media destruction and aneurysm formation, probably by means of reduced plasmindependent activation of pro-MMPs secreted by infiltrating macrophages. 13 It was also reported that overexpression of TIMP-1 reduced atherosclerotic lesions in apoE-deficient mice 14 and prevented aortic aneurysm degeneration and rupture in a rat model. 15 
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Thus, several lines of evidence support a role for MMP system components in the development and progression of atherosclerosis. Like most other MMPs, stromelysin-1 (MMP-3) is secreted as a proenzyme; it can be activated by plasmin, and, once activated, it can convert other pro-MMPs, eg, procollagenase and progelatinase B, into their active forms (reviewed in References 16 and 17). Because of its expression in atherosclerotic plaques, 8 its broad substrate specificity, and its central role in the activation of other pro-MMPs, 16 -18 we investigated a potential contribution of MMP-3 to the development and progression of atherosclerosis. Therefore, atherosclerosis-susceptible mice deficient in apoE and MMP-3 (ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ ) and apoE-deficient controls (ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ ) were kept on a cholesterol-rich diet for up to 30 weeks. Analysis of the atherosclerotic aortas indicated that MMP-3 contributes to plaque destabilization and aneurysm formation.
Methods

Generation of Mice Colonies and Experimental Protocol
MMP-3-deficient (MMP-3 Ϫ/Ϫ ) mice with the genetic background B10.RIII were a kind gift of Dr. J. Mudgett (Merck Research Laboratories, Rahway, NJ) 19 ; they were rederived by back-crossing with C57/BL6 mice. ApoE-deficient (ApoE Ϫ/Ϫ ) mice (50% C57/BL6:50% 129SVJ) 20 were also rederived by back-crossing onto a C57/BL6 background, yielding 75% C57/BL6:25% 129SVJ. Genomic DNA was extracted from tail tips for genotyping of offspring by Southern blotting for MMP-3 and by polymerase chain reaction for apoE (data not shown). Mice were kept in microisolation cages on a 12-hour day/night cycle and fed a high-fat, cholesterol-rich diet from the age of 5 weeks onward (wt/wt, 47% sucrose, 20% casein, 19% butter, 1% corn oil, 1.25% cholesterol, 0.5% cholic acid, 0.5% NaCl, 5% ␣-cellulose, 5% mineral mix, 1% vitamin mix, 1% choline chloride, 0.3% DLmethionine, and 0.13% ␣-tocopherol).
After an overnight fast, the mice were anesthetized by intraperitoneal injection of 60 mg/kg pentobarbital (Nembutal™, Abbott Laboratories). Blood was collected from the vena cava in 1/10 volume EDTA, pH 6.8, and centrifuged at 3000 rpm for 10 minutes; the plasma was stored at Ϫ20°C and used for cholesterol determination. The arterial system was perfused with 4% paraformaldehyde in PBS, dissected, rinsed with PBS, and stored in 20% sucrose. After incubation in 4% paraformaldehyde (3 hours for aortas, overnight for the hearts), samples were embedded in ornithine carbamyl transferase (Tissue-Tek, Laborimpex), snap-frozen in precooled 2-methylbutane, and stored at Ϫ80°C. Eight-micron-thick sections were made from tissue around the cardiac valves and at 80-m intervals throughout the aorta. The aortic arch was dissected free of tissue and frozen at Ϫ80°C. Gonadal, retroperitoneal, and subcutaneous fat pads were removed and weighed.
All animal experiments were approved by the local ethics committee and were performed in accordance with the guiding principles of the American Physiological Society and the International Society on Thrombosis and Hemostasis. 21
Zymographic Analysis
The aortic arch was pulverized by submersion in LN 2 and incubated for 1 hour at 4°C with 100 L extraction buffer (10 mmol/L sodium phosphate buffer, pH 7.2, containing 150 mmol/L NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, and 0.2% sodium azide). After extensive vortexing and centrifugation (13 000 rpm for 5 minutes), the protein concentration of the supernatant was determined (BCA protein assay, Pierce), and equivalent amounts of total protein were subjected to zymography on casein-containing gels without or with addition of 5 g/mL human plasminogen to the gel. 22
Histology and Immunocytochemistry
Eight-micron-thick sections were stained with hematoxylin-eosin, oil red O, Verhoeff-van Gieson's, or Sirius red stain under standard conditions. Plaque sizes or stained areas were quantified by computer-assisted image analysis with Quantimed 600 image analysis software (Leica). For each animal, 9 sections were analyzed throughout the thoracic aorta, and data are reported as meanϮSD with 5 animals in each group. Statistical analysis was performed by unpaired Student's t test.
The topographic relationship between MMP-3 or u-PA and macrophages in the atherosclerotic vessel wall was studied by double-immunofluorescence labeling combined with fluorescence microscopy and digital imaging. MMP-3 or u-PA was identified with specific rabbit polyclonal antibodies (custom-made in our laboratory, at a final concentration of 50 g/mL). Macrophages were detected by using a rat monoclonal anti-mouse Mac-3 antigen (clone M3/84, Pharmingen), and SMCs, with biotinylated mouse anti-human smooth muscle ␣-actin (clone A14, Sigma Chemical Co). Tissue cryosections, fixed with paraformaldehyde, were quenched with 0.1 mol/L sodium borohydrate in PBS for 15 minutes at room temperature, blocked against nonspecific binding, and incubated overnight at 4°C with cocktails of the primary antibodies. Secondary antibody mixtures of horse anti-mouse IgG coupled to Texas Red and goat anti-rabbit IgG conjugated with FITC were used. The sections were mounted in Vectashield (Vector Laboratories) solution containing 4Ј,6-diamidino-2-phenylindole dihydrochloride (DAPI) as a nuclear counterstain and examined with a Nikon Optiphot microscope equipped with appropriate filters. To correlate the localization of different antigens, images of the same microscopic fields were taken with each filter set (FITC, Texas Red, and DAPI) with a Nikon digital camera and merged by using Adobe Photoshop software. Table) . The mice with a single or a combined genetic deficiency had a 62.5% C57/BL6:25% B10.RIII:12.5% 129SVJ genetic background; they appeared healthy, and no macroscopic abnormalities were observed. Five (3 males, 2 females) ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ or ApoE Ϫ/Ϫ : MMP-3 Ϫ/Ϫ mice were kept on the cholesterol-rich diet for 30 weeks. At the time of sacrifice, body weights were not significantly different between both strains (25Ϯ3.5 vs 25Ϯ1.6 g, meanϮSD). Also, the weight of the different fat pads was comparable: 78Ϯ4 vs 84Ϯ20 g for retroperitoneal, 200Ϯ49 vs 180Ϯ23 g for subcutaneous, and 260Ϯ23 vs 250Ϯ63 g for gonadal adipose tissue. The plasma cholesterol levels were also comparable for ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ and ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ mice: 1400Ϯ410 vs 1200Ϯ410 mg/dL (meanϮSEM). (Figures 1a and 1e ). Quantification by image analysis of the lipid content, defined as the percentage of plaque area that was stained with oil red O, confirmed these observations ( Figure 3A) .
Results
Generation of Mice Colonies
Analysis of Atherosclerotic Aortas
Staining of fibrillar collagen with Sirius red (Figures 1b  and 1f ) revealed that the atherosclerotic lesions of ApoE Ϫ/Ϫ : MMP-3 ϩ/ϩ mice contained significantly less collagen than did those of ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ mice; the stained area, normalized to plaque size, was 55Ϯ0.8% vs 66Ϯ2.3% (10 sections throughout the thoracic aorta analyzed per animal; PϽ0.01, nϭ5). Verhoeff-van Gieson's staining of elastin revealed that the elastic lamina showed more frequent aneurysms in the thoracic and abdominal aortas of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice. Aneurysms are characterized by fragmentation of elastic membranes, thinning of the aortic wall, and rupture of elastic membranes across the media (Figures 1c and 1g ). This feature is also associated with loss of ␣-actin SMC staining ( Figures  1d and 1h) . 
Analysis of Infiltrating Macrophages
Single immunostaining for Mac-3 indicated the more abundant presence of macrophages in atherosclerotic plaques of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ compared with ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ aor-tas (Figures 4e and 4f) . Quantification of the Mac-3-stained area throughout the thoracic aorta confirmed this observation ( Figure 3B ). Macrophages appeared to infiltrate more in the ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ plaques, whereas they remained closer to the surface in the ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ plaques. The observed Mac-3 staining pattern corresponded to that seen with oil red O (Figure 1 ), suggesting that macrophages occur abundantly as foam cells.
Single immunostaining for MMP-3 revealed very low expression in nonatherosclerotic aortas from ApoE ϩ/ϩ :MMP-3 ϩ/ϩ mice (Figure 4a ) but considerable upregulation in atherosclerotic lesions of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice (Figure 4c) , where it was found predominantly in the plaque shoulders and the fibrous cap, colocalized with macrophages ( Figures  4e and 4g ). MMP-3 immunostaining was not observed in (Figure 5d ) aortas. u-PA was localized in high amounts in cellular components of the lesion cap and in areas of the necrotic core (Figure 5c ), where it colocalized with macrophages (Figures 5e and 5g) . A similar topographic pattern, but with less intense staining, was observed in ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ plaques (Figures 5d, 5f, and 5h ).
Zymographic analysis of aortic extracts on casein gels containing plasminogen confirmed the presence of u-PA activity in atherosclerotic tissues from ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ aortas, whereas u-PA was not detected in ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ aortas (data not shown). Use of an ELISA specific for murine u-PA 23 ng/mg protein, meanϮSEM) but not in extracts of ApoE Ϫ/Ϫ : MMP-3 Ϫ/Ϫ , ApoE ϩ/ϩ :MMP-3 ϩ/ϩ , or ApoE ϩ/ϩ :MMP-3 Ϫ/Ϫ aortas (Ͻ0.6 ng/mg protein). These data suggest that the u-PA levels in aortic extracts of ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ mice are below the detection limit of these assays but do not allow us to conclude that u-PA is totally absent (cf weak immunostaining for u-PA in Figure 5d ).
Discussion
Atherosclerosis is an inflammatory process in which plaques are formed in the intimal layer of the vessel wall as a result of accumulation of lipid-rich macrophages, SMCs, and lipids and deposition of extracellular matrix. Plaques may become unstable and rupture, triggering intravascular thrombosis and tissue ischemia. 1, 2, 24 Alternatively, the atherosclerotic vessel wall may dilate owing to degradation of collagen and elastin with media destruction, leading to aneurysm formation and rupture of the weakened vessel wall. 25, 26 The plasminogen/ plasmin and MMP systems have been implicated in the pathogenesis of atherosclerosis and aneurysm formation, 24, 27 largely based on analysis of in situ expression of components of both systems. Indeed, in atherosclerotic plaques as well as in aortic, cerebral, and cardiac aneurysms, enhanced expression of plasminogen activators and inhibitors and of MMP system components was reported. 3-12,28 -31 In several in vivo animal models, it was shown that overexpression of plasminogen activator inhibitor-1 or of TIMP-1 prevented aortic aneurysm formation and rupture. 15, 32 Impaired plasmin or MMP activity may thus contribute to the growth and stabilization of atherosclerotic plaques, whereas increased activities may be associated with plaque rupture and aneurysm formation. Plasmin can degrade only some components of the extracellular matrix directly, such as laminin and fibronectin, whereas others, such as elastin and collagen, are degraded by MMPs. The plasminogen/plasmin system can, however, play a role in the activation of several pro-MMPs (reviewed in References 16 and 17) .
It was previously shown that a u-PA or a tissue-type plasminogen activator deficiency in mice did not alter the size or the predilection site of early fatty streaks and more advanced plaques. However, u-PA deficiency protected against aneurysm formation. It was suggested that u-PA-generated plasmin causes activation of macrophage-secreted pro-MMPs, resulting in the degradation of elastin and fibrillar collagen. 13 In the present study, the role of stromelysin-1 (MMP-3) in this phenomenon was investigated by using mice with a combined deficiency of apoE and MMP-3 (ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ ) kept on a cholesterolrich diet. All mice used in this study were of the same genetic background. Pronounced differences in atherosclerotic lesion formation have indeed been reported in mice with different genetic backgrounds. [33] [34] [35] This study revealed a potential dual effect of MMP-3. Whereas the cholesterol-rich diet caused extensive atherosclerotic plaque formation in both ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ and ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ mice, the size of the plaques throughout the thoracic aorta was significantly smaller in wild-type mice for MMP-3. Immunostaining confirmed enhanced expression of MMP-3 in atherosclerotic versus nonatherosclerotic aortas of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ mice and showed its colocalization with macrophages, whereas zymography with aortic extracts confirmed MMP-3 activity. Macrophages were more abundant and infiltrated in the plaques of ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ than of ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ mice; enhanced oil red O staining and colocalization with macrophages suggest that foam cells are predominant. Furthermore, enhanced expression of u-PA, colocalizing with macrophages, was observed in atherosclerotic MMP-3 wild-type aortas. In vitro studies with cultured macrophages have previously revealed that in the presence of plasminogen, wild-type but not u-PA-deficient macrophages can activate secreted pro-MMP-3. 13 Our data are thus compatible with the hypothesis that enhanced expression of u-PA by macrophages contributes to the activation of macrophagesecreted pro-MMP-3, most likely by plasmin generation. Active MMP-3 may then contribute to plaque destabilization by degrading matrix components. Thus, we speculate that reduced u-PA secretion and plasmin generation in MMP-3 Ϫ/Ϫ compared with MMP-3 ϩ/ϩ atherosclerotic plaques may affect migration and accumulation of macrophages; reduced matrix degradation in the absence of MMP-3 could in turn contribute to impaired infiltration of macrophages into the lesions. Interestingly, it has been reported that the presence of a genetic variant of the human MMP-3 promoter, resulting in reduced gene expression, is associated with accelerated progression of atherosclerotic lesions. 36 On the other hand, aortic aneurysm formation was significantly more frequent in ApoE Ϫ/Ϫ :MMP-3 ϩ/ϩ than in ApoE Ϫ/Ϫ :MMP-3 Ϫ/Ϫ aortas. Elastin fibers were eroded, fragmented, and eventually completely degraded. At the site of media destruction, loss of ␣-actin-stained SMCs was also observed.
Taken together, our findings indicate that MMP-3 on the one hand contributes to plaque destabilization, possibly by degrading matrix components, and on the other hand, promotes aneurysm formation by degrading the elastic lamina. It remains to be shown whether and which other MMPs may play a role in these phenomena. Recently, Pyo et al 37 provided direct genetic evidence that MMP-9, which can be activated by MMP-3, plays an essential role in a mouse model of nonatherosclerotic aneurysm formation. The biological effects observed in this study may thus be mediated by MMP-3 activity directly, by activation of other pro-MMPs, or even by other (proteolytic) systems. It has been reported previously that eg, progelatinase B and procollagenase, can be activated by MMP-3 (cf References 16 and 17).
